AND
THE MEMBER REPRESENTATIVE.
PAGE | ||||
ARTICLE I DEFINITIONS | 2 | |||
ARTICLE II THE MERGERS | 2 | |||
2.1 MP Holdings Merger | 2 | |||
2.2 OnRamp Merger | 3 | |||
2.3 Closing | 5 | |||
ARTICLE III EFFECT OF MERGER; AMOUNT OF TRANSACTION CONSIDERATION; PAYMENTS, ISSUANCES AND DEPOSITS; EXCHANGE PROCEDURES | 5 | |||
3.1 Treatment of Equity Interests | 5 | |||
3.2 Withholding Rights | 6 | |||
3.3 Rounding | 6 | |||
3.4 Amount of Transaction Consideration | 6 | |||
3.5 Payments and Deposits | 9 | |||
3.6 Issuance of Notes | 10 | |||
3.7 MP Holdings Exchange Procedure | 10 | |||
3.8 OnRamp Exchange Procedure | 10 | |||
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANIES | 10 | |||
4.1 Company Organization | 10 | |||
4.2 Authorization; Enforceability | 11 | |||
4.3 No Violations | 11 | |||
4.4 Consents and Approvals | 11 | |||
4.5 Capitalization | 12 | |||
4.6 Subsidiaries | 13 | |||
4.7 Financial Statements | 13 | |||
4.8 Absence of Certain Changes or Events | 14 | |||
4.9 Legal Proceedings, Etc. | 15 | |||
4.10 Taxes | 15 | |||
4.11 Title to Properties and Related Matters | 19 | |||
4.12 Company Intellectual Property; Proprietary Rights; Employee Restrictions | 20 | |||
4.13 Contracts | 23 | |||
4.14 Inventory; Warranties | 25 | |||
4.15 Employees; Employee Benefits | 25 | |||
4.16 Consultants | 28 | |||
4.17 Environmental, Health, and Safety Matters | 28 | |||
4.18 Compliance with Applicable Laws; Privacy | 28 | |||
4.19 Permits | 28 | |||
4.20 Accounts Receivable | 29 | |||
4.21 Accounts Payable | 29 | |||
4.22 Insurance | 29 |
PAGE | ||||
4.23 Bank Accounts; Powers of Attorney | 29 | |||
4.24 Minute Books and Company Records | 29 | |||
4.25 Related Person Indebtedness and Contracts | 30 | |||
4.26 Brokers | 30 | |||
4.27 Customers and Suppliers | 30 | |||
4.28 Solvency | 30 | |||
4.29 Nature and Business of OnRamp | 31 | |||
4.30 Nature and Business of MP Holdings | 31 | |||
4.31 Disclosure | 31 | |||
ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE MEMBERS | 31 | |||
5.1 Organization | 31 | |||
5.2 Authorization; Enforceability | 31 | |||
5.3 No Violations | 32 | |||
5.4 Ownership and Title to Equity Interest | 32 | |||
5.5 Advice | 32 | |||
5.6 Brokers | 32 | |||
5.7 Investment Intent | 32 | |||
ARTICLE VI REPRESENTATIONS AND WARRANTIES OF THE ACQUISITION PARTIES | 33 | |||
6.1 Organization | 33 | |||
6.2 Authorization; Enforceability | 33 | |||
6.3 Consents and Approvals; No Violations | 33 | |||
6.4 Parent Common Stock | 34 | |||
6.5 Brokers | 34 | |||
6.6 Sufficient Funds | 34 | |||
6.7 Disclosure | 34 | |||
ARTICLE VII CONDUCT PRIOR TO THE EFFECTIVE TIME | 34 | |||
7.1 Conduct of Business | 34 | |||
7.2 [Reserved] | 36 | |||
7.3 Other Negotiations | 36 | |||
7.4 Required Consents | 37 | |||
7.5 Resignations and Releases | 37 | |||
7.6 Supporting Documents | 37 | |||
7.7 Escrow Agreement | 37 | |||
7.8 Restrictive Covenants Agreements | 38 | |||
7.9 Employment Agreements | 38 | |||
7.10 Registration Rights Agreement | 38 | |||
7.11 Security Agreement | 38 | |||
7.12 NuTech Termination/Amendment | 38 | |||
7.13 Closing Opinion | 38 | |||
7.14 Options and Warrants | 38 | |||
7.15 Termination of Related Party Agreements | 38 | |||
7.16 Accuracy of Representations and Warranties of Companies and Members | 39 | |||
7.17 Accuracy of Acquisition Parties’ Representations and Warranties | 39 |
Page ii
PAGE | ||||
ARTICLE VIII ADDITIONAL AGREEMENTS | 39 | |||
8.1 Access to Properties and Records | 39 | |||
8.2 Reasonable Best Efforts, Etc. | 39 | |||
8.3 Material Events | 39 | |||
8.4 Fees and Expenses | 39 | |||
8.5 Supplements to Schedules | 40 | |||
8.6 Appointment of Member Representative | 40 | |||
8.7 Access to Employees, Customers, Vendors, and Contractors | 41 | |||
8.8 Confidential Information | 41 | |||
8.9 Director and Officer Indemnification | 42 | |||
8.10 Member Release | 43 | |||
8.11 Articles of Merger | 43 | |||
8.12 Tax Matters | 43 | |||
8.13 Further Action | 44 | |||
ARTICLE IX CONDITIONS TO THE OBLIGATIONS OF THE ACQUISITION PARTIES | 44 | |||
9.1 Compliance with Covenants | 44 | |||
9.2 Amendment or Termination of NuTech Agreement | 44 | |||
ARTICLE X CONDITIONS TO THE OBLIGATIONS OF THE COMPANIES | 44 | |||
10.1 Compliance with Covenants | 44 | |||
ARTICLE XI TERMINATION | 45 | |||
11.1 Termination | 45 | |||
11.2 Effect of Termination | 45 | |||
ARTICLE XII INDEMNIFICATION | 46 | |||
12.1 Indemnity Obligations | 46 | |||
12.2 Duration | 48 | |||
12.3 Direct Claims | 49 | |||
12.4 Third Person Claims | 49 | |||
12.5 Escrow Stock | 50 | |||
12.6 Knowledge | 50 | |||
12.7 Limitations of Liability | 50 | |||
12.8 Adjustment to Transaction Consideration | 51 | |||
12.9 Sole and Exclusive Remedy; Offset | 51 | |||
12.10 Assignment of Claims | 51 | |||
12.11 No Duplicative Losses; Determination of Losses | 51 | |||
12.12 Cooperation | 51 |
Page iii
PAGE | ||||
ARTICLE XIII MISCELLANEOUS PROVISIONS | 52 | |||
13.1 Responsibility for Filing Returns | 52 | |||
13.2 Certain Taxes and Fees | 52 | |||
13.3 No Additional Warranties or Representations; Due Diligence | 52 | |||
13.4 Amendment | 53 | |||
13.5 Waiver of Compliance | 53 | |||
13.6 Notices | 53 | |||
13.7 Binding Effect; Assignment | 54 | |||
13.8 No Third Party Beneficiaries | 54 | |||
13.9 Public Announcements | 54 | |||
13.10 Counterparts | 54 | |||
13.11 Entire Agreement | 54 | |||
13.12 Construction | 54 | |||
13.13 Headings | 54 | |||
13.14 Schedules and Exhibits | 55 | |||
13.15 Governing Law; Venue | 55 | |||
13.16 Severability | 55 | |||
13.17 Specific Performance | 55 | |||
13.18 Waiver of Jury Trial | 55 | |||
13.19 Arbitration | 55 |
Page iv
Exhibit A | Form of Notes | |
Exhibit B | Resignation and Release | |
Exhibit C | Escrow Agreement | |
Exhibit D | Restrictive Covenants Agreement | |
Exhibit E | Employment Agreement | |
Exhibit F | Registration Rights Agreement | |
Exhibit G | Security Agreement |
Schedule I | Definitions | |
Schedule 1.155 | Surgical Biologics Products | |
Schedule 3.4(a) | Transaction Consideration Schedule | |
Schedule 5.4 | Members | |
Schedule 7.1 | Conduct of Business | |
Schedule 7.8 | Restrictive Covenants Agreement Signatories | |
Schedule 7.9 | Employment Agreement Signatories |
2
3
4
PAYMENTS, ISSUANCES AND DEPOSITS; EXCHANGE PROCEDURES
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
Membrane Products Holdings, LLC,
Surgical Biologics, LLC, and/or
Member Representative
4891 Gresham Ridge Drive
Kennesaw, Georgia 30144
Attention: John Daniel
Facsimile: 770-218-6195
Email: jdaniel@surgicalbio.com
Five Concourse Parkway, Suite 2350
Atlanta, Georgia 30328
Attention: Andrew P. Kaiser, Esq.
Facsimile: (404) 760-0225
Email: akaiser@jktlaw.com
811 Livingston Court
Suite B
Marietta, Georgia 30067
Attention: Parker H. “Pete” Petite
Facsimile: (678) 384-6741
Email: Pete.Petit@thepetitgroup.com
811 Livingston Court
Suite B
Marietta, Georgia 30067
Attention: Roberta McCaw
Facsimile: (678) 384-6741
Email: robertamccaw@comcast.net
53
54
55
56
MIMEDX GROUP, INC. | ||||
By: | /s/ Parker H. Petit | |||
Parker H. Petit, Chairman and CEO | ||||
MP HOLDINGS ACQUISITION SUB, LLC | ||||
By: | /s/ Parker H. Petit | |||
Parker H. Petit, Manager | ||||
ORCI ACQUISITION SUB, LLC | ||||
By: | /s/ Parker H. Petit | |||
Parker H. Petit, Manager | ||||
MEMBRANE PRODUCTS HOLDINGS, LLC | ||||
By: | /s/ Kenneth S. Hurt | |||
Name: | Kenneth S. Hurt | |||
Title: | Manager | |||
ONRAMP CAPITAL INVESTMENTS, LLC | ||||
By: | /s/ John R. Daniel | |||
John R. Daniel, Operating Manager |
/s/ John R. Daniel | ||||
JOHN R. DANIEL, in his capacity as the Member Representative |
MEMBERS: | ||||
/s/ John R. Daniel | ||||
JOHN R. DANIEL | ||||
/s/ Yvette F. Daniel | ||||
YVETTE F. DANIEL | ||||
/s/ Randall Spencer | ||||
RANDALL SPENCER | ||||
/s/ Katie Christie | ||||
KATIE CHRISTIE | ||||
/s/ Kenneth S. Hurt | ||||
KENNETH S. HURT | ||||
SAGESSE GENERALE, LLC | ||||
By: | /s/ Nicholas Steele | |||
Name: | Nicholas Steele | |||
Title: | Manager | |||
CURIEUX LIMITED CO. | ||||
By: | /s/ Robert Frohwein | |||
Name: | Robert Frohwein | |||
Title: | Manager | |||
Exhibit A | — | Form of the Notes | ||
Exhibit B | — | Form of Resignation and Release | ||
Exhibit C | — | Form of Escrow Agreement | ||
Exhibit D | — | Restrictive Covenants Agreement | ||
Exhibit E | — | Employment Agreement | ||
Exhibit F | — | Registration Rights Agreement | ||
Exhibit G | — | Security Agreement |
Schedule I | — | Definitions | ||
Schedule 1.155 | — | Surgical Biologics Products | ||
Schedule 3.4(a) | — | Transaction Consideration Schedule | ||
Schedule 5.4 | — | Members | ||
Schedule 7.1 | — | Conduct of Business | ||
Schedule 7.8 | — | Restrictive Covenants Agreement Signatories | ||
Schedule 7.9 | — | Employment Agreement Signatories |
Schedule I, Page 1
Schedule I, Page 2
Schedule I, Page 3
Schedule I, Page 4
Schedule I, Page 5
Schedule I, Page 6
Schedule I, Page 7
Schedule I, Page 8
Schedule I, Page 9
Schedule I, Page 10
Schedule I, Page 11
Schedule I, Page 12
Schedule I, Page 13
Schedule I, Page 14
Schedule I, Page 15
(copy attached)
(copy attached)
(copy attached)
(copy attached)
(copy attached)
(copy attached)
If to the Company to: | MiMedx Group, Inc. 811 Livingston Court. SE, Suite B Marietta, Georgia 30067 Attn: General Counsel Fax No: (678) 384-6741 |
If to any Shareholder to: | The address of such Shareholder as set forth in the records of the Company |
COMPANY: MiMedx Group, Inc. | ||||
By: | ||||
Name: | ||||
Title: |
REGISTRATION RIGHTS AGREEMENT
Signature for Corporate, Partnership, or other Equity Shareholder: | Signature for Individual Shareholder: | |||
(Signature) | ||||
(Print Name of Entity) | ||||
Print Name: | ||||
By: | ||||||
Print Name: | ||||||
Print Title: |
(copy attached)